Displaying 25 - 32 of 32
Immune-Mediated and Cholestatic Diseases
5

CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion"  - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
5

CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion"  - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
5

CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion"  - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View
Displaying 25 - 32 of 32